Valuation: NewCardio, Inc.

Market Cap 9L 7L 7L 6L 11.96L 8.24Cr 12.16L 81.96L 32.05L 4.13Cr 32.36L 31.66L 14Cr P/E 2009
-1.65x
P/E 2010 -2.11x
Enterprise Value 32.77L 28.3L 26.6L 24.19L 45.47L 31Cr 46.22L 3.12Cr 1.22Cr 16Cr 1.23Cr 1.2Cr 52Cr EV / Sales 2009
-
EV / Sales 2010 10,81,28,357x
Free-Float
75.73%
Yield 2009 *
-
Yield 2010 -
Change 5-day change 1-year change 3-year change Capi.($)
-2.50%+62.50% - - 40
-1.28%-0.96%+20.30%+11.24% 22TCr
-0.71%-1.13%-4.02%-19.91% 14TCr
-1.68%+4.14%-17.85%+31.80% 14TCr
+0.27%+5.11%-49.76%+0.72% 7.51TCr
-1.04%+2.10%+17.05%+16.26% 5.28TCr
+0.69%-0.51%-16.49%-15.46% 5.07TCr
-0.51%+1.75%+24.61%+22.39% 4.19TCr
-0.32%+1.31%+41.37%+49.96% 4.05TCr
-0.14%+2.68%+0.40%+4.27% 3.33TCr
Average -0.72%+1.61%+1.73%+11.25% 8.82TCr
Weighted average by Cap. -0.82%+1.12%+0.51%+9.17%

Financials

2009 2010
Net sales - 0.26 0.22 0.21 0.19 0.36 24.61 0.36 2.45 0.96 12.33 0.97 0.95 40.96
Net income -95.91L -82.83L -77.84L -70.79L -1.33Cr -92Cr -1.35Cr -9.12Cr -3.57Cr -46Cr -3.6Cr -3.52Cr -152.61Cr -1.15Cr -99.29L -93.3L -84.86L -1.6Cr -109.93Cr -1.62Cr -11Cr -4.27Cr -55Cr -4.32Cr -4.22Cr -182.94Cr
Net Debt -14.11L -12.19L -11.45L -10.41L -19.58L -13Cr -19.9L -1.34Cr -52.46L -6.76Cr -52.98L -51.83L -22Cr 24.15L 20.86L 19.6L 17.83L 33.51L 23Cr 34.07L 2.3Cr 89.8L 12Cr 90.67L 88.7L 38Cr
Logo NewCardio, Inc.
NewCardio, Inc. (NewCardio), through its wholly owned subsidiary, NewCardio Technologies, Inc. (NewCardio Technologies), operates as a development-stage cardiac diagnostic technology provider focused on the research, development and commercialization of products and services for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of new drugs under development. The Company is focused on the development of a platform technology for its products, which will improve the diagnostic accuracy and value of the standard 12-lead electrocardiogram (ECG). The Company’s core technology platform provides real-time, three-dimensional (3D) analysis of the heart's electrical activity, as detected at the body surface by standard 12-lead ECG electrodes. ECG input signals are typically sampled at 500 hertz (500 times per second).
Employees
-